XHKG
8026
Market cap88mUSD
Oct 05, Last price
4.49HKD
1D
-0.44%
Jan 2017
96.93%
IPO
-88.18%
Name
China Brilliant Global Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
China Brilliant Global Limited operates as an investment holding firm primarily engaged in the gold and jewelry sector. Its core activities include the research, development, design, wholesale, and retail of gold and jewelry products, along with associated services, across Hong Kong and mainland China. The company's operations are divided into three key segments: Gold and Jewellery Business, Lending Business, and Fintech Business. Beyond its jewelry interests, it also offers a range of banking services such as accepting deposits, extending credit, advising on and arranging credit financing, and providing various money services, in addition to direct money lending. Established in 1989, the company, formerly known as Prosten Health Holdings Limited, adopted its current name, China Brilliant Global Limited, in May 2018. Its corporate headquarters are situated in Sheung Wan, Hong Kong, and it functions as a subsidiary of Brilliant Chapter Limited.
Key people
Chief Financial Officer, Company Secretary · since 2018
Chunhua Zhang
Executive Chairman of the Board · since 2018
Chunping Zhang
Chief Executive Officer, Executive Director · since 2023
Mei Yan Chan
Non-Executive Independent Director · since 2018
Non-Executive Independent Director · since 2023
Yin Peng
Non-Executive Independent Director · since 2023
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||